https://www.selleckchem.com/products/OSI-906.html
PURPOSE To describe persistent remnants of dexamethasone intravitreal implant (DEX implant) and evaluate the risk factors for remnant persistence in patients who received a DEX implant. METHODS This retrospective observational study involved a retrospective chart review of 133 eyes from 129 patients who received DEX implant injection. RESULTS Seventeen eyes of 17 patients (12.78%) exhibited remnant persistence 1 year after DEX implant injection; eight eyes (13.33%) were diagnosed with branching retinal vein occlusion, three eyes (14
Like
Comment
Share
